Microchip implanted in liver tumors could personalize cancer treatment
NCT ID NCT07193862
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a small implantable device placed directly into liver tumors from colorectal cancer. The device releases tiny amounts of several chemotherapy and immunotherapy drugs to see how the tumor responds. After a few days, the device is removed along with the tumor during planned surgery. The goal is to check if the procedure is safe and can help guide future treatment choices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
implantable microdevice containing chemotherapy and immunotherapy drugs (doxorubicin, FOLFOX, botensilimab, balstilimab, bevacizumab, FOLFIRI, FOLFIRINOX, AGEN2373)
What this could lead to
If successful, this approach could help doctors choose the most effective drugs for each patient's liver tumors before surgery.
What could go wrong
This is a very early safety study with only 10 participants, so it cannot yet prove the device improves treatment outcomes. The device itself could cause complications or fail to provide useful information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Long Island Jewish Medical Center
RECRUITINGNew Hyde Park, New York, 11040, United States
Contact
-
RJ Zuckerberg
RECRUITINGLake Success, New York, 11042, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••